Ildong Pharmaceutical Co., Ltd. (KRX:249420)
South Korea · Delayed Price · Currency is KRW 15,320
-10 (-0.07%)
Aug 7, 2026, 3:30 PM KST
Ildong Pharmaceutical Financials Overview
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 572,954 | 566,934 | 614,941 | 600,758 | 637,714 | 560,132 |
Revenue Growth | -4.48% | -7.81% | 2.36% | -5.79% | 13.85% | -0.30% |
Gross Profit Gross Profit Growth | 227,646 | 219,581 | 233,282 | 213,665 | 236,088 | 219,174 |
Operating Income Operating Income Growth | 22,570 | 17,322 | 11,431 | -53,418 | -73,666 | -54,412 |
Net Income Net Income Growth | 34,905 | 27,664 | -4,576 | -78,928 | -141,585 | -99,705 |
Earnings Per Share EPS Growth | 1137.71 | 936.77 | -164.00 | -2920.01 | -5379.82 | -4192.00 |
EPS Growth | - | - | - | - | - | - |
| Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
South Korea South Korea Growth | 556,326 | 605,432 | 590,690 | 623,119 | 547,488 |
Japan Japan Growth | 4,139 | 2,243 | 3,775 | 8,864 | 3,413 |
Southeast Asia Southeast Asia Growth | 2,870 | 3,521 | 3,011 | - | - |
Other Other Growth | 3,599 | 3,745 | 3,282 | 5,054 | 4,477 |
Total Total Growth | 566,934 | 614,941 | 600,758 | 637,714 | 560,132 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 59,070 | 64,955 | 84,872 | 81,279 | 78,746 | 154,681 |
Total Debt Total Debt Growth | 133,646 | 144,408 | 205,548 | 212,726 | 207,748 | 226,155 |
Net Cash (Debt) Net Cash Growth | -74,576 | -79,452 | -120,675 | -131,447 | -129,002 | -71,474 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -2355.11 | -2585.64 | -4320.27 | -4862.98 | -4896.88 | -3004.97 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 17,327 | 18,951 | 28,293 | -36,615 | -53,541 | -11,366 |
Capital Expenditures CapEx Growth | -13,571 | -13,647 | -10,679 | -13,201 | -11,873 | -14,626 |
Free Cash Flow Free Cash Flow Growth | 3,757 | 5,304 | 17,614 | -49,817 | -65,413 | -25,992 |
Free Cash Flow Growth | -81.58% | -69.89% | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 39.73% | 38.73% | 37.94% | 35.57% | 37.02% | 39.13% |
Operating Margin | 3.94% | 3.06% | 1.86% | -8.89% | -11.55% | -9.71% |
Pretax Margin | 6.95% | 5.60% | -1.74% | -15.69% | -18.79% | -25.21% |
Profit Margin | 6.09% | 4.88% | -0.74% | -13.14% | -22.20% | -17.80% |
FCF Margin | 0.66% | 0.94% | 2.86% | -8.29% | -10.26% | -4.64% |
| Fiscal Year | Current | FY 2025 |
|---|---|---|
| Period Ending | Aug '26 Aug 8, 2026 | Dec '25 Dec 31, 2025 |
Dividend Per Share Dividend Per Share Growth | 200.000 | 200.000 |
Dividend Per Share Growth | 0% | - |
Dividend Yield | 1.30% | 0.52% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 8, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 13.47 | 43.85 | - | - | - | - |
Forward PE | - | 14.76 | 14.76 | 14.76 | 14.76 | 14.76 |
P/FCF Ratio | 128.50 | 228.70 | 18.67 | - | - | - |
PS Ratio | 0.84 | 2.14 | 0.54 | 0.84 | 1.20 | 1.43 |